Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Emergence of NDM-1-producing Klebsiella pneumoniae in Greece: evidence of a widespread clonal outbreak.

Politi L, Gartzonika K, Spanakis N, Zarkotou O, Poulou A, Skoura L, Vrioni G, Tsakris A.

J Antimicrob Chemother. 2019 Aug 1;74(8):2197-2202. doi: 10.1093/jac/dkz176.

PMID:
31065697
2.

Open Repair of a Ruptured Abdominal Aortic Aneurysm on a Patient Under Rivaroxaban and Clopidogrel.

Poulou A, Alexiou E, Geroulakos G, Lazaris AM.

Ann Vasc Surg. 2019 Jul;58:379.e5-379.e8. doi: 10.1016/j.avsg.2018.09.042. Epub 2019 Jan 24.

PMID:
30684617
3.

Multiple Giant Coronary Artery Aneurysms Surgically Treated with Bypass Grafting: A Challenging Rarity.

Kostopanagiotou K, Poulou A, Chatzis A, Khoury M.

Case Rep Surg. 2018 Aug 29;2018:2096902. doi: 10.1155/2018/2096902. eCollection 2018.

4.

The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.

Paschou SA, Palioura E, Kothonas F, Myroforidis A, Loi V, Poulou A, Goumas K, Effraimidis G, Vryonidou A.

Endocr J. 2018 Nov 29;65(11):1121-1125. doi: 10.1507/endocrj.EJ18-0243. Epub 2018 Aug 21.

5.

Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.

Protonotariou E, Poulou A, Politi L, Sgouropoulos I, Metallidis S, Kachrimanidou M, Pournaras S, Tsakris A, Skoura L.

Int J Antimicrob Agents. 2018 Sep;52(3):331-337. doi: 10.1016/j.ijantimicag.2018.04.004. Epub 2018 Apr 11.

PMID:
29654892
6.

Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease.

Paschou SA, Kothonas F, Lafkas A, Myroforidis A, Loi V, Terzi T, Karagianni O, Poulou A, Goumas K, Vryonidou A.

Int J Endocrinol. 2018 Mar 5;2018:6712901. doi: 10.1155/2018/6712901. eCollection 2018.

7.

High-dose vs. Low-dose Proton Pump Inhibitors post-endoscopic hemostasis in patients with bleeding peptic ulcer. A meta-analysis and meta-regression analysis.

Sgourakis G, Chatzidakis G, Poulou A, Malliou P, Argyropoulos T, Ravanis G, Vagia A, Kpogho I, Briki A, Tsuruhara H, Stankovičová T.

Turk J Gastroenterol. 2018 Jan;29(1):22-31. doi: 10.5152/tjg.2018.17143.

8.

Performance of the modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for detecting ESBLs in Pseudomonas aeruginosa.

Poulou A, Grivakou E, Politi L, Dimitroulia E, Tsakris A.

Diagn Microbiol Infect Dis. 2018 Jan;90(1):70-71. doi: 10.1016/j.diagmicrobio.2017.09.006. Epub 2017 Sep 19. No abstract available.

PMID:
29103874
9.

Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study.

Pournaras S, Dafopoulou K, Del Franco M, Zarkotou O, Dimitroulia E, Protonotariou E, Poulou A, Zarrilli R, Tsakris A; Greek Study Group on Acinetobacter Antimicrobial Resistance.

Int J Antimicrob Agents. 2017 Jun;49(6):749-753. doi: 10.1016/j.ijantimicag.2017.01.028. Epub 2017 Apr 18.

PMID:
28427842
10.

First report of an NDM-1 metallo-β-lactamase-producing Acinetobacter baumannii clinical isolate in Greece.

Voulgari E, Politi L, Pitiriga V, Dendrinos J, Poulou A, Georgiadis G, Tsakris A.

Int J Antimicrob Agents. 2016 Dec;48(6):761-762. doi: 10.1016/j.ijantimicag.2016.09.006. Epub 2016 Sep 29. No abstract available.

PMID:
27773496
11.

Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.

Dimitriadis P, Protonotariou E, Varlamis S, Poulou A, Vasilaki O, Metallidis S, Tsakris A, Malisiovas N, Skoura L, Pournaras S.

Int J Antimicrob Agents. 2016 Sep;48(3):321-3. doi: 10.1016/j.ijantimicag.2016.05.017. Epub 2016 Jul 7.

PMID:
27451087
12.

Emergence of OXA-162 Carbapenemase- and DHA-1 AmpC Cephalosporinase-Producing Sequence Type 11 Klebsiella pneumoniae Causing Community-Onset Infection in Greece.

Voulgari E, Poulou A, Dimitroulia E, Politi L, Ranellou K, Gennimata V, Markou F, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1862-4. doi: 10.1128/AAC.01514-15.

13.

Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates.

Tsakris A, Poulou A, Bogaerts P, Dimitroulia E, Pournaras S, Glupczynski Y.

J Clin Microbiol. 2015 Apr;53(4):1245-51. doi: 10.1128/JCM.03318-14. Epub 2015 Feb 4.

14.

Neuroinvasive phlebovirus infection in Greece: a case report.

Papa A, Mallias J, Tsergouli K, Markou F, Poulou A, Milidis T.

Intervirology. 2014;57(6):393-5. doi: 10.1159/000363505. Epub 2014 Oct 31.

15.

Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.

Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, Vrioni G, Tsakris A.

J Hosp Infect. 2014 Apr;86(4):260-6. doi: 10.1016/j.jhin.2014.02.001. Epub 2014 Feb 20.

PMID:
24680473
16.

Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.

Poulou A, Grivakou E, Vrioni G, Koumaki V, Pittaras T, Pournaras S, Tsakris A.

J Clin Microbiol. 2014 May;52(5):1483-9. doi: 10.1128/JCM.03361-13. Epub 2014 Feb 26.

17.

Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.

Pournaras S, Poulou A, Dafopoulou K, Chabane YN, Kristo I, Makris D, Hardouin J, Cosette P, Tsakris A, Dé E.

Antimicrob Agents Chemother. 2014;58(2):828-32. doi: 10.1128/AAC.01439-13. Epub 2013 Nov 18.

18.

Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.

Poulou A, Voulgari E, Vrioni G, Koumaki V, Xidopoulos G, Chatzipantazi V, Markou F, Tsakris A.

J Clin Microbiol. 2013 Oct;51(10):3176-82. doi: 10.1128/JCM.01244-13. Epub 2013 Jul 12.

19.

A combined disk test for direct differentiation of carbapenemase-producing enterobacteriaceae in surveillance rectal swabs.

Pournaras S, Zarkotou O, Poulou A, Kristo I, Vrioni G, Themeli-Digalaki K, Tsakris A.

J Clin Microbiol. 2013 Sep;51(9):2986-90. doi: 10.1128/JCM.00901-13. Epub 2013 Jul 10.

20.

Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.

Kristo I, Pitiriga V, Poulou A, Zarkotou O, Kimouli M, Pournaras S, Tsakris A.

Int J Antimicrob Agents. 2013 Apr;41(4):383-7. doi: 10.1016/j.ijantimicag.2012.12.003. Epub 2013 Feb 1.

PMID:
23375981
21.

Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?

Voulgari E, Poulou A, Koumaki V, Tsakris A.

Future Microbiol. 2013 Jan;8(1):27-39. doi: 10.2217/fmb.12.130. Review.

PMID:
23252491
22.

Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination.

Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, Chatzipantazi V, Markou F, Tsakris A.

J Clin Microbiol. 2012 Aug;50(8):2618-23. doi: 10.1128/JCM.00459-12. Epub 2012 May 30.

23.

Detection of Pseudomonas aeruginosa isolates of the international clonal complex 11 carrying the blaPER-1 extended-spectrum β-lactamase gene in Greece.

Ranellou K, Kadlec K, Poulou A, Voulgari E, Vrioni G, Schwarz S, Tsakris A.

J Antimicrob Chemother. 2012 Feb;67(2):357-61. doi: 10.1093/jac/dkr471. Epub 2011 Nov 8.

PMID:
22072497
24.

Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.

Tsakris A, Themeli-Digalaki K, Poulou A, Vrioni G, Voulgari E, Koumaki V, Agodi A, Pournaras S, Sofianou D.

J Clin Microbiol. 2011 Aug;49(8):2804-9. doi: 10.1128/JCM.00666-11. Epub 2011 Jun 1.

25.

Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a New OXY-2-type variant in the community.

Tsakris A, Poulou A, Markou F, Pitiriga V, Piperaki ET, Kristo I, Pournaras S.

Antimicrob Agents Chemother. 2011 Jul;55(7):3164-8. doi: 10.1128/AAC.00102-11. Epub 2011 May 9.

26.

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

Pournaras S, Vrioni G, Neou E, Dendrinos J, Dimitroulia E, Poulou A, Tsakris A.

Int J Antimicrob Agents. 2011 Mar;37(3):244-7. doi: 10.1016/j.ijantimicag.2010.10.031. Epub 2011 Jan 13.

PMID:
21236643
27.

Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

Poulou A, Spanakis N, Pournaras S, Pitiriga V, Ranellou K, Markou F, Tsakris A.

J Antimicrob Chemother. 2010 Dec;65(12):2538-42. doi: 10.1093/jac/dkq363. Epub 2010 Sep 28.

PMID:
20876622
28.

A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.

Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, Petropoulou D, Sofianou D.

J Antimicrob Chemother. 2010 Aug;65(8):1664-71. doi: 10.1093/jac/dkq210. Epub 2010 Jun 11.

PMID:
20542902
29.

Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae.

Pournaras S, Poulou A, Voulgari E, Vrioni G, Kristo I, Tsakris A.

J Antimicrob Chemother. 2010 Aug;65(8):1604-7. doi: 10.1093/jac/dkq190. Epub 2010 Jun 3.

PMID:
20522444
30.

Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.

Pournaras S, Kristo I, Vrioni G, Ikonomidis A, Poulou A, Petropoulou D, Tsakris A.

J Clin Microbiol. 2010 Jul;48(7):2601-4. doi: 10.1128/JCM.02134-09. Epub 2010 May 26.

31.

In vivo acquisition of a plasmid-mediated bla(KPC-2) gene among clonal isolates of Serratia marcescens.

Tsakris A, Voulgari E, Poulou A, Kimouli M, Pournaras S, Ranellou K, Kosmopoulou O, Petropoulou D.

J Clin Microbiol. 2010 Jul;48(7):2546-9. doi: 10.1128/JCM.00264-10. Epub 2010 May 12.

32.

Characterization of the ascending colon fluids in ulcerative colitis.

Vertzoni M, Goumas K, Söderlind E, Abrahamsson B, Dressman JB, Poulou A, Reppas C.

Pharm Res. 2010 Aug;27(8):1620-6. doi: 10.1007/s11095-010-0158-y. Epub 2010 Apr 29.

PMID:
20428929
33.

Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds.

Pournaras S, Poulou A, Tsakris A.

J Antimicrob Chemother. 2010 Jul;65(7):1319-21. doi: 10.1093/jac/dkq124. Epub 2010 Apr 15. Review.

PMID:
20395214
34.

Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.

Tsakris A, Poulou A, Kristo I, Pittaras T, Spanakis N, Pournaras S, Markou F.

J Clin Microbiol. 2009 Nov;47(11):3524-9. doi: 10.1128/JCM.01099-09. Epub 2009 Sep 23.

35.

Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.

Tsakris A, Poulou A, Themeli-Digalaki K, Voulgari E, Pittaras T, Sofianou D, Pournaras S, Petropoulou D.

J Clin Microbiol. 2009 Nov;47(11):3420-6. doi: 10.1128/JCM.01314-09. Epub 2009 Sep 2.

36.

Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory.

Tsakris A, Kristo I, Poulou A, Themeli-Digalaki K, Ikonomidis A, Petropoulou D, Pournaras S, Sofianou D.

J Clin Microbiol. 2009 Feb;47(2):362-7. doi: 10.1128/JCM.01922-08. Epub 2008 Dec 10.

37.

First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.

Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S.

J Antimicrob Chemother. 2008 Dec;62(6):1257-60. doi: 10.1093/jac/dkn364. Epub 2008 Sep 4.

PMID:
18772158
38.

Escherichia hermannii as the sole isolate from a patient with purulent conjunctivitis.

Poulou A, Dimitroulia E, Markou F, Tsakris A.

J Clin Microbiol. 2008 Nov;46(11):3848-9. doi: 10.1128/JCM.01119-08. Epub 2008 Sep 3.

39.

Acute ischemic colitis during scuba diving: report of a unique case.

Goumas K, Poulou A, Tyrmpas I, Dandakis D, Bartzokis S, Tsamouri M, Barbati K, Soutos D.

World J Gastroenterol. 2008 May 28;14(20):3262-5.

40.

Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.

Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Vrizas D, Diomidous M, Pournaras S, Markou F.

Clin Microbiol Infect. 2008 Jun;14(6):588-94. doi: 10.1111/j.1469-0691.2008.01996.x. Epub 2008 Apr 5.

41.

Emergence of carbapenem-resistant Enterobacter cloacae carrying VIM-4 metallo-beta-lactamase and SHV-2a extended-spectrum beta-lactamase in a conjugative plasmid.

Ikonomidis A, Spanakis N, Poulou A, Pournaras S, Markou F, Tsakris A.

Microb Drug Resist. 2007 Winter;13(4):221-6. doi: 10.1089/mdr.2007.768.

PMID:
18184047
42.

Role of endoscopic intervention in biliary complications of hepatic hydatid cyst disease.

Goumas K, Poulou A, Dandakis D, Tyrmpas I, Georgouli A, Sgourakis G, Soutos D, Karaliotas K.

Scand J Gastroenterol. 2007 Sep;42(9):1113-9.

PMID:
17710679
43.

Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.

Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Pournaras S, Markou F.

J Antimicrob Chemother. 2007 Jul;60(1):136-9. Epub 2007 May 8.

PMID:
17491004
44.

Characterization of In3Mor, a new integron carrying VIM-1 metallo-beta-lactamase and sat1 gene, from Morganella morganii.

Tsakris A, Ikonomidis A, Spanakis N, Poulou A, Pournaras S.

J Antimicrob Chemother. 2007 Apr;59(4):739-41. Epub 2007 Mar 6.

PMID:
17341470
45.

Fatal massive hemolysis as the first manifestation of Clostridium perfringens septicemia in a patient with non-systematic or local predisposing disorder.

Poulou A, Manolis EN, Markou F, Ropotos A, Georgiadis M, Tsakris A.

Anaerobe. 2007 Feb;13(1):40-2. Epub 2007 Jan 11.

PMID:
17222573
46.

Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?

Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A.

World J Gastroenterol. 2006 Feb 7;12(5):739-46.

47.

A rare case of Brucella melitensis infection in an obstetrician during the delivery of a transplacentally infected infant.

Poulou A, Markou F, Xipolitos I, Skandalakis PN.

J Infect. 2006 Jul;53(1):e39-41. Epub 2005 Oct 24.

PMID:
16249034

Supplemental Content

Loading ...
Support Center